Cargando…
Plasma gelsolin as a biomarker of inflammation
The prognostic implications of declining plasma gelsolin levels have been documented after a diverse variety of acute insults. Because gelsolin concentrations fall prior to the development of complications, a pathophysiological role for gelsolin depletion has been postulated in delayed multiorgan fa...
Autor principal: | DiNubile, Mark J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656232/ https://www.ncbi.nlm.nih.gov/pubmed/19105851 http://dx.doi.org/10.1186/ar2547 |
Ejemplares similares
-
Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia
por: Catteeuw, Julie V., et al.
Publicado: (2021) -
Delayed Therapy with Plasma Gelsolin Improves Survival in Murine Pneumococcal Pneumonia
por: Yang, Zhiping, et al.
Publicado: (2017) -
Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia
por: DiNubile, Mark J, et al.
Publicado: (2022) -
Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza
por: Yang, Zhiping, et al.
Publicado: (2020) -
Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study
por: Strandberg, Timo E., et al.
Publicado: (2022)